Founded in 2001, Cell>Point is a privately held biopharmaceutical company that is developing and commercializing intra-nuclear molecular imaging and therapeutic compounds for imaging cancer, diabetes, and cardiovascular disease, and the treatment of solid tumor and certain blood borne cancers using platform technologies licensed from The University of Texas M.D. Anderson Cancer Center (“M.D. Anderson”), Houston, Texas.
- Cell>Point Announces Postive Results from 99mTc-Oncardia (EC- G) trial at the Unviersity of Chicago Medical Center to image and montior therapy for Head and Neck Cacer.
- Cell>Point Announces Encouraging Results from 99mTc -EC-G Phase 2a Trial in Evaluating Presence and Severity of Coronary Artery Disease
7120 E. Orchard Rd., Suite 350
Centennial, Colorado 80111